Ana Fernandez-Ots1, Juanita Crook1. 1. British Columbia Cancer Agency, Center for the Southern Interior, 399 Royal Avenue, Kelowna, British Columbia, Canada V1Y 5L3.
Abstract
AIM: This manuscript reviews the English language literature on the use of intensity modulated radiation therapy (IMRT) for gynecologic malignancies, focusing on the treatment cervical cancer. BACKGROUND: Radiation therapy plays a key role in both definitive and adjuvant treatment of these patients, although efforts continue to minimize acute and chronic toxicity. IMRT is an attractive option because of the potential to dose escalate to the target while sparing organs at risk. METHODS AND MATERIALS: The English language literature was reviewed for relevant studies. RESULTS: Multiple heterogeneous studies have showed dosimetric and clinical benefits with reduction in acute and late gastrointestinal, genitourinary and hematologic toxicity, especially in the post hysterectomy scenario and for dose escalation to para-aortic nodes. Consensus is evolving regarding necessary margins and target delineation in the context of organ movement and tumor shrinkage during the course of radiotherapy. Protocols with daily soft-tissue visualization are being investigated. CONCLUSIONS: Consistency in approach and reporting are vital in order to acquire the data to justify the considerable increased expense of IMRT.
AIM: This manuscript reviews the English language literature on the use of intensity modulated radiation therapy (IMRT) for gynecologic malignancies, focusing on the treatment cervical cancer. BACKGROUND: Radiation therapy plays a key role in both definitive and adjuvant treatment of these patients, although efforts continue to minimize acute and chronic toxicity. IMRT is an attractive option because of the potential to dose escalate to the target while sparing organs at risk. METHODS AND MATERIALS: The English language literature was reviewed for relevant studies. RESULTS: Multiple heterogeneous studies have showed dosimetric and clinical benefits with reduction in acute and late gastrointestinal, genitourinary and hematologic toxicity, especially in the post hysterectomy scenario and for dose escalation to para-aortic nodes. Consensus is evolving regarding necessary margins and target delineation in the context of organ movement and tumor shrinkage during the course of radiotherapy. Protocols with daily soft-tissue visualization are being investigated. CONCLUSIONS: Consistency in approach and reporting are vital in order to acquire the data to justify the considerable increased expense of IMRT.
Authors: Elizabeth A Kidd; Barry A Siegel; Farrokh Dehdashti; Janet S Rader; Sasa Mutic; David G Mutch; Matthew A Powell; Perry W Grigsby Journal: Int J Radiat Oncol Biol Phys Date: 2009-10-31 Impact factor: 7.038
Authors: Linda van de Bunt; Uulke A van der Heide; Martijn Ketelaars; Gerard A P de Kort; Ina M Jürgenliemk-Schulz Journal: Int J Radiat Oncol Biol Phys Date: 2005-06-22 Impact factor: 7.038
Authors: Arno J Mundt; Anthony E Lujan; Jacob Rotmensch; Steven E Waggoner; S Diane Yamada; Gini Fleming; John C Roeske Journal: Int J Radiat Oncol Biol Phys Date: 2002-04-01 Impact factor: 7.038
Authors: John C Roeske; Anthony Lujan; Richard C Reba; Bill C Penney; S Diane Yamada; Arno J Mundt Journal: Radiother Oncol Date: 2005-07-18 Impact factor: 6.280
Authors: W A Peters; P Y Liu; R J Barrett; R J Stock; B J Monk; J S Berek; L Souhami; P Grigsby; W Gordon; D S Alberts Journal: J Clin Oncol Date: 2000-04 Impact factor: 44.544
Authors: Frederick B Stehman; Shamshad Ali; Henry M Keys; Laila I Muderspach; Weldon E Chafe; Donald G Gallup; Joan L Walker; Deborah Gersell Journal: Am J Obstet Gynecol Date: 2007-11 Impact factor: 8.661
Authors: Patricia J Eifel; Kathryn Winter; Mitchell Morris; Charles Levenback; Perry W Grigsby; Jay Cooper; Marvin Rotman; David Gershenson; David G Mutch Journal: J Clin Oncol Date: 2004-03-01 Impact factor: 44.544
Authors: Matthias M Manuel; Linda P Cho; Paul J Catalano; Antonio L Damato; David T Miyamoto; Clare M Tempany; Ehud J Schmidt; Akila N Viswanathan Journal: Radiother Oncol Date: 2016-06-16 Impact factor: 6.280
Authors: Arya Amini; Peter E DeWitt; Yevgeniy Vinogradskiy; Chad G Rusthoven; Cem Altunbas; Tracey E Schefter; Christine M Fisher Journal: Rep Pract Oncol Radiother Date: 2016-03-02
Authors: Abel Cordoba; Philippe Nickers; Emmanuelle Tresch; Bernard Castelain; Eric Leblanc; Fabrice Narducci; Florence Le Tinier; Anne Lesoin; Thomas Lacornerie; Eric Lartigau Journal: Rep Pract Oncol Radiother Date: 2015-07-03